Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value:
$245.15M
Total Bought:
$0
Total Sold:
$35.69M
Net Transaction:
-$35.69M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Dyne Therapeutics, Inc.(DYN)4,951,3033,451,303-1,500,000$65.85M$97.98M39.97%+$32.13M
Entrada Therapeutics, Inc.(TRDA)4,425,7844,425,7840$66.79M$62.71M25.58%-$4.07M
iTeos Therapeutics, Inc.2,738,7852,738,7850$29.99M$37.36M15.24%+$7.37M
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,1720$16.54M$27.76M11.32%+$11.22M
Repare Therapeutics, Inc.2,242,6362,242,6360$16.37M$10.56M4.31%-$5.81M
Adaptimmune Therapeutics plcADR(ADAPY)5,555,4615,555,4610$4.41M$8.78M3.58%+$4.37M
Harpoon Therapeutics, Inc.313,1360-313,136$3.56M$0—-$3.56M
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q1 2024 | TickerTrail